4.67
0.07 (1.52%)
0.07 (1.52%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 224,825 |
|
|||||
| News | - | ||||||
| Day High | 4.73 | Low High |
|||||
| Day Low | 4.47 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| KemPharm Inc | KMPH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.07 | 1.52% | 4.67 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.60 | 4.47 | 4.73 | 4.69 | 4.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,839 | 224,825 | $ 4.62 | $ 1,038,229 | - | 4.00 - 15.6967 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:59:53 | formt | 175 | $ 4.67 | USD |
Period:
Draw Mode:
KemPharm Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 160.76M | 34.42M | 34.24M | $ 28.65M | $ -696.20k | -2.90 | -9.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 611.51k | 0.80% |
KemPharm News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KMPH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.15 | 5.17 | 4.32 | 4.71 | 375,477 | -0.48 | -9.32% |
| 1 Month | 4.32 | 5.2299 | 4.00 | 4.49 | 533,129 | 0.35 | 8.1% |
| 3 Months | 5.37 | 5.73 | 4.00 | 4.77 | 542,423 | -0.70 | -13.04% |
| 6 Months | 8.11 | 9.4299 | 4.00 | 6.06 | 516,859 | -3.44 | -42.42% |
| 1 Year | 9.85 | 15.6967 | 4.00 | 8.92 | 558,133 | -5.18 | -52.59% |
| 3 Years | 1.69 | 18.15 | 0.18 | 5.81 | 1,244,643 | 2.98 | 176.33% |
| 5 Years | 4.30 | 18.15 | 0.18 | 5.63 | 746,336 | 0.37 | 8.6% |
KemPharm Description
| KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of treatments for the central nervous system, CNS, and rare disease indications. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety. |